Evidence map›Paper›PMID 37418020›Full record

ArticleInternational immunology2023

Contributions of the N-terminal flanking residues of an antigenic peptide from the Japanese cedar pollen allergen Cry j 1 to the T-cell activation by HLA-DP5.

Seisuke Kusano, Sho Ueda, Daisuke Oryoji, Aya Toyoumi, Akiko Hashimoto-Tane, Hiroyuki Kishi, Hiroshi Hamana, Atsushi Muraguchi, Hui Jin, Hisashi Arase and 9 more

Open access · hybridAbstract read
In one paragraph

Article in International immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Seisuke KusanoRIKEN Structural Biology Laboratory, Yokohama 230-0045, Japan.
Sho UedaInstitute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan.
Daisuke OryojiInstitute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan.
Aya ToyoumiInstitute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan.
Akiko Hashimoto-TaneRIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
Hiroyuki KishiDepartment of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
Hiroshi HamanaDepartment of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
Atsushi MuraguchiDepartment of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama 930-0194, Japan.
Hui JinDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.
Hisashi AraseDepartment of Immunochemistry, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan.ORCID 0000-0002-1153-3166
Hiroko MiyaderaDepartment of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, Japan.
Reiko KishikawaDepartment of Allergology, The National Hospital Organization Fukuoka National Hospital, Fukuoka 811-1394, Japan.
Yasunobu YoshikaiMedical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Hisakata YamadaMedical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan.
Ken YamamotoDepartment of Medical Biochemistry, Kurume University School of Medicine, Kurume 830-0011, Japan.
Yasuharu NishimuraDepartment of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
Takashi SaitoRIKEN Center for Integrative Medical Sciences, Yokohama 230-0045, Japan.
Takehiko SasazukiInstitute for Advanced Study, Kyushu University, Fukuoka 812-8582, Japan.
Shigeyuki YokoyamaRIKEN Structural Biology Laboratory, Yokohama 230-0045, Japan.ORCID 0000-0003-3133-7338
Kyushu University · JPUniversity of Toyama · JPRIKEN Center for Integrative Medical Sciences · JPRIKEN Center for Sustainable Resource Science · JPThe University of Osaka · JPKumamoto University · JPKurume University Medical Center · JPNational Hospital Organization · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cry j 1 is a major allergen present in Japanese cedar (Cryptomeria japonica) pollens. Peptides with the core sequence of KVTVAFNQF from Cry j 1 ('pCj1') bind to HLA-DP5 and activate Th2 cells. In this study, we noticed that Ser and Lys at positions -2 and -3, respectively, in the N-terminal flanking (NF) region to pCj1 are conserved well in HLA-DP5-binding allergen peptides. A competitive binding assay showed that the double mutation of Ser(-2) and Lys(-3) to Glu [S(P-2)E/K(P-3)E] in a 13-residue Cry j 1 peptide (NF-pCj1) decreased its affinity for HLA-DP5 by about 2-fold. Similarly, this double mutation reduced, by about 2-fold, the amount of NF-pCj1 presented on the surface of mouse antigen-presenting dendritic cell line 1 (mDC1) cells stably expressing HLA-DP5. We established NF-pCj1-specific and HLA-DP5-restricted CD4+ T-cell clones from HLA-DP5 positive cedar pollinosis (CP) patients, and analyzed their IL-2 production due to the activation of mouse TG40 cells expressing the cloned T-cell receptor by the NF-pCj1-presenting mDC1 cells. The T-cell activation was actually decreased by the S(P-2)E/K(P-3)E mutation, corresponding to the reduction in the peptide presentation by this mutation. In contrast, the affinity of NF-pCj1·HLA-DP5 for the T-cell receptor was not affected by the S(P-2)E/K(P-3)E mutation, as analyzed by surface plasmon resonance. Considering the positional and side-chain differences of these NF residues from previously reported T-cell activating sequences, the mechanisms of enhanced T-cell activation by Ser(-2) and Lys(-3) of NF-pCj1 may be novel.

Indexed as

AllergensCryptomeriaAnimalsAntigens, PlantMicePeptidesPlant ProteinsPollenReceptors, Antigen, T-CellAllergensAntigens, PlantPeptidesPlant ProteinsReceptors, Antigen, T-CellimmunogenicityJapanese cedar pollinosispeptide flanking region

Identifiers

PMID37418020
PMCPMC10478803
OpenAlexW4383480812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.